- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Influenza Diagnostics market will register a 6.1% CAGR in terms of revenue, the global market size will reach $ 2843.3 million by 2025, from $ 2241.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Diagnostics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Diagnostics market by type, application, key manufacturers and key regions and countries.
This study considers the Influenza Diagnostics value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
RIDT
RT-PCR
Cell Culture
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
POCT
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BD
Sekisui Diagnostics
Abbott (Include Alere)
SIEMENS
Analytik Jena
Roche
Meridian Bioscience
Quidel
BioMerieux
Thermo Fisher
Response Biomedical
Focus Diagnostics
Enigma Diagnostics
SA Scientific
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Influenza Diagnostics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Influenza Diagnostics market by identifying its various subsegments.
Focuses on the key global Influenza Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Influenza Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Diagnostics Consumption 2015-2025
2.1.2 Influenza Diagnostics Consumption CAGR by Region
2.2 Influenza Diagnostics Segment by Type
2.2.1 RIDT
2.2.2 RT-PCR
2.2.3 Cell Culture
2.3 Influenza Diagnostics Consumption by Type
2.3.1 Global Influenza Diagnostics Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Diagnostics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Diagnostics Sale Price by Type (2015-2020)
2.4 Influenza Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Influenza Diagnostics Consumption by Application
2.5.1 Global Influenza Diagnostics Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Diagnostics Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Diagnostics Sale Price by Type (2015-2020)
3 Global Influenza Diagnostics by Company
3.1 Global Influenza Diagnostics Sales Market Share by Company
3.1.1 Global Influenza Diagnostics Sales by Company (2018-2020)
3.1.2 Global Influenza Diagnostics Sales Market Share by Company (2018-2020)
3.2 Global Influenza Diagnostics Revenue Market Share by Company
3.2.1 Global Influenza Diagnostics Revenue by Company (2018-2020)
3.2.2 Global Influenza Diagnostics Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Diagnostics Sale Price by Company
3.4 Global Influenza Diagnostics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Diagnostics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Influenza Diagnostics by Regions
4.1 Influenza Diagnostics by Regions
4.2 Americas Influenza Diagnostics Consumption Growth
4.3 APAC Influenza Diagnostics Consumption Growth
4.4 Europe Influenza Diagnostics Consumption Growth
4.5 Middle East & Africa Influenza Diagnostics Consumption Growth
5 Americas
5.1 Americas Influenza Diagnostics Consumption by Countries
5.1.1 Americas Influenza Diagnostics Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Diagnostics Value by Countries (2015-2020)
5.2 Americas Influenza Diagnostics Consumption by Type
5.3 Americas Influenza Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Diagnostics Consumption by Regions
6.1.1 APAC Influenza Diagnostics Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Diagnostics Value by Regions (2015-2020)
6.2 APAC Influenza Diagnostics Consumption by Type
6.3 APAC Influenza Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Influenza Diagnostics by Countries
7.1.1 Europe Influenza Diagnostics Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Diagnostics Value by Countries (2015-2020)
7.2 Europe Influenza Diagnostics Consumption by Type
7.3 Europe Influenza Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Influenza Diagnostics by Countries
8.1.1 Middle East & Africa Influenza Diagnostics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Diagnostics Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Diagnostics Consumption by Type
8.3 Middle East & Africa Influenza Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Diagnostics Distributors
10.3 Influenza Diagnostics Customer
11 Global Influenza Diagnostics Market Forecast
11.1 Global Influenza Diagnostics Consumption Forecast (2021-2025)
11.2 Global Influenza Diagnostics Forecast by Regions
11.2.1 Global Influenza Diagnostics Forecast by Regions (2021-2025)
11.2.2 Global Influenza Diagnostics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Diagnostics Forecast by Type
11.8 Global Influenza Diagnostics Forecast by Application
12 Key Players Analysis
12.1 BD
12.1.1 Company Information
12.1.2 Influenza Diagnostics Product Offered
12.1.3 BD Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 BD Latest Developments
12.2 Sekisui Diagnostics
12.2.1 Company Information
12.2.2 Influenza Diagnostics Product Offered
12.2.3 Sekisui Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sekisui Diagnostics Latest Developments
12.3 Abbott (Include Alere)
12.3.1 Company Information
12.3.2 Influenza Diagnostics Product Offered
12.3.3 Abbott (Include Alere) Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott (Include Alere) Latest Developments
12.4 SIEMENS
12.4.1 Company Information
12.4.2 Influenza Diagnostics Product Offered
12.4.3 SIEMENS Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 SIEMENS Latest Developments
12.5 Analytik Jena
12.5.1 Company Information
12.5.2 Influenza Diagnostics Product Offered
12.5.3 Analytik Jena Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Analytik Jena Latest Developments
12.6 Roche
12.6.1 Company Information
12.6.2 Influenza Diagnostics Product Offered
12.6.3 Roche Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Roche Latest Developments
12.7 Meridian Bioscience
12.7.1 Company Information
12.7.2 Influenza Diagnostics Product Offered
12.7.3 Meridian Bioscience Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Meridian Bioscience Latest Developments
12.8 Quidel
12.8.1 Company Information
12.8.2 Influenza Diagnostics Product Offered
12.8.3 Quidel Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Quidel Latest Developments
12.9 BioMerieux
12.9.1 Company Information
12.9.2 Influenza Diagnostics Product Offered
12.9.3 BioMerieux Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 BioMerieux Latest Developments
12.10 Thermo Fisher
12.10.1 Company Information
12.10.2 Influenza Diagnostics Product Offered
12.10.3 Thermo Fisher Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Thermo Fisher Latest Developments
12.11 Response Biomedical
12.11.1 Company Information
12.11.2 Influenza Diagnostics Product Offered
12.11.3 Response Biomedical Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Response Biomedical Latest Developments
12.12 Focus Diagnostics
12.12.1 Company Information
12.12.2 Influenza Diagnostics Product Offered
12.12.3 Focus Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Focus Diagnostics Latest Developments
12.13 Enigma Diagnostics
12.13.1 Company Information
12.13.2 Influenza Diagnostics Product Offered
12.13.3 Enigma Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Enigma Diagnostics Latest Developments
12.14 SA Scientific
12.14.1 Company Information
12.14.2 Influenza Diagnostics Product Offered
12.14.3 SA Scientific Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SA Scientific Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Influenza Diagnostics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
